Weekly: Halozyme Therapeutics (HALO: $36.55) falls for a third consecutive week, a three-week fall of 7.6%; -59c [1.6%]

Press/Media

PeriodOct 14 2023

Media coverage

1

Media coverage

  • TitleWeekly: Halozyme Therapeutics (HALO: $36.55) falls for a third consecutive week, a three-week fall of 7.6%; -59c [1.6%]
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date10/14/23
    PersonsMary Daly